Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship

被引:81
作者
Lustberg, Maryam B. [1 ]
Kuderer, Nicole M. [2 ]
Desai, Aakash [3 ]
Bergerot, Cristiane [4 ]
Lyman, Gary H. [5 ]
机构
[1] Yale Univ, Dept Med, Sch Med, New Haven, CT USA
[2] Adv Canc Res Grp, Kirkland, WA 98033 USA
[3] Mayo Clin, Dept Med, Sch Med, Rochester, MN USA
[4] Inst Unity Ensino & Pesquisa, Ctr Canc Brasilia, Brasilia, Brazil
[5] Fred Hutchinson Canc Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
关键词
ACUTE MYELOID-LEUKEMIA; INDUCED PERIPHERAL NEUROPATHY; QUALITY-OF-LIFE; COLONY-STIMULATING FACTOR; IDIOPATHIC PULMONARY-FIBROSIS; CLINICAL-PRACTICE GUIDELINES; MEASURING FINANCIAL TOXICITY; PLACEBO-CONTROLLED TRIAL; BREAST-CANCER; COGNITIVE IMPAIRMENT;
D O I
10.1038/s41571-023-00776-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite the importance of chemotherapy-associated adverse events in oncology practice and the broad range of interventions available to mitigate them, limited systematic efforts have been made to identify, critically appraise and summarize the totality of evidence on the effectiveness of these interventions. Herein, we review the most common long-term (continued beyond treatment) and late or delayed (following treatment) adverse events associated with chemotherapy and other anticancer treatments that pose major threats in terms of survival, quality of life and continuation of optimal therapy. These adverse effects often emerge during and continue beyond the course of therapy or arise among survivors in the months and years following treatment. For each of these adverse effects, we discuss and critically evaluate their underlying biological mechanisms, the most commonly used pharmacological and non-pharmacological treatment strategies, and evidence-based clinical practice guidelines for their appropriate management. Furthermore, we discuss risk factors and validated risk-assessment tools for identifying patients most likely to be harmed by chemotherapy and potentially benefit from effective interventions. Finally, we highlight promising emerging supportive-care opportunities for the ever-increasing number of cancer survivors at continuing risk of adverse treatment effects. The effective management of treatment-related events remains an unmet need in oncology. The authors of this Review discuss the underlying biological mechanisms, risk factors, most commonly used pharmacological and non-pharmacological management strategies, and clinical practice guidelines for the most common long-term (continuing beyond treatment) and late or delayed (following treatment) adverse events associated with chemotherapy and other anticancer treatments.
引用
收藏
页码:527 / 542
页数:16
相关论文
共 288 条
  • [1] The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy
    Ahles, TA
    Saykin, AJ
    Noll, WW
    Furstenberg, CT
    Guerin, S
    Cole, B
    Mott, LA
    [J]. PSYCHO-ONCOLOGY, 2003, 12 (06) : 612 - 619
  • [2] Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science
    Ahles, Tim A.
    Root, James C.
    Ryan, Elizabeth L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30) : 3675 - 3686
  • [3] Protective effects of spironolactone against anthracycline-induced cardiomyopathy
    Akpek, Mahmut
    Ozdogru, Ibrahim
    Sahin, Omer
    Inanc, Mevlude
    Dogan, Ali
    Yazici, Cevat
    Berk, Veli
    Karaca, Halit
    Kalay, Nihat
    Oguzhan, Abdurrahman
    Ergin, Ali
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (01) : 81 - 89
  • [4] Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines
    Alexandre, Joachim
    Cautela, Jennifer
    Ederhy, Stephane
    Damaj, Ghandi Laurent
    Salem, Joe-Elie
    Barlesi, Fabrice
    Farnault, Laure
    Charbonnier, Aude
    Mirabel, Mariana
    Champiat, Stephane
    Cohen-Solal, Alain
    Cohen, Ariel
    Dolladille, Charles
    Thuny, Franck
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (18):
  • [5] Alfano Catherine M, 2019, Am Soc Clin Oncol Educ Book, V39, P625, DOI 10.1200/EDBK_238267
  • [6] Financial Hardships Experienced by Cancer Survivors: A Systematic Review
    Altice, Cheryl K.
    Banegas, Matthew P.
    Tucker-Seeley, Reginald D.
    Yabroff, K. Robin
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (02):
  • [7] Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)
    Ambrosone, Christine B.
    Zirpoli, Gary R.
    Hutson, Alan D.
    McCann, William E.
    McCann, Susan E.
    Barlow, William E.
    Kelly, Kara M.
    Cannioto, Rikki
    Sucheston-Campbell, Lara E.
    Hershman, Dawn L.
    Unger, Joseph M.
    Moore, Halle C. F.
    Stewart, James A.
    Isaacs, Claudine
    Hobday, Timothy J.
    Salim, Muhammad
    Hortobagyi, Gabriel N.
    Gralow, Julie R.
    Budd, George T.
    Albain, Kathy S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (08) : 804 - +
  • [8] Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation
    Andersen, Barbara L.
    DeRubeis, Robert J.
    Berman, Barry S.
    Gruman, Jessie
    Champion, Victoria L.
    Massie, Mary Jane
    Holland, Jimmie C.
    Partridge, Ann H.
    Bak, Kate
    Somerfield, Mark R.
    Rowland, Julia H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15) : 1605 - U118
  • [9] ESHRE guideline: female fertility preservation
    Anderson, Richard A.
    Amant, Frederic
    Braat, Didi
    D'Angelo, Arianna
    Lopes, Susana M. Chuva de Sousa
    Demeestere, Isabelle
    Dwek, Sandra
    Frith, Lucy
    Lambertini, Matteo
    Maslin, Caroline
    Moura-Ramos, Mariana
    Nogueira, Daniela
    Rodriguez-Wallberg, Kenny
    Vermeulen, Nathalie
    [J]. HUMAN REPRODUCTION OPEN, 2020, 2020 (04)
  • [10] [Anonymous], 2016, OBSTET GYNECOL, V127, pE93